These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 20619606)
1. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial. Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606 [TBL] [Abstract][Full Text] [Related]
2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of levetiracetam: a review of three pivotal clinical trials. Privitera M Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy. Li S; Cao J; Xiao N; Cai F J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083 [TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy. Lee YJ; Kang HC; Kim HD; Lee JS Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743 [TBL] [Abstract][Full Text] [Related]
8. Rapid dosage titration of levetiracetam in children. Vaisleib II; Neft RA Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118 [TBL] [Abstract][Full Text] [Related]
9. Intravenous levetiracetam in children with epilepsy. Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751 [TBL] [Abstract][Full Text] [Related]
10. Levetiracetam: a long-term follow-up study of efficacy and safety. Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age. Krief P; Li Kan ; Maytal J J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Perry MS; Benatar M Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408 [TBL] [Abstract][Full Text] [Related]
13. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Coppola G; Mangano S; Tortorella G; Pelliccia A; Fels A; Romano A; Nardello R; Habetswallner F; Licciardi F; Operto FF; Pascotto A Epilepsy Res; 2004 Mar; 59(1):35-42. PubMed ID: 15135165 [TBL] [Abstract][Full Text] [Related]
14. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B; Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423 [TBL] [Abstract][Full Text] [Related]
15. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy. Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Grosso S; Franzoni E; Coppola G; Iannetti P; Verrotti A; Cordelli DM; Marchiani V; Pascotto A; Spalice A; Acampora B; Morgese G; Balestri P Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359 [TBL] [Abstract][Full Text] [Related]
17. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy. von Stuelpnagel C; Holthausen H; Kluger G Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601 [TBL] [Abstract][Full Text] [Related]
18. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573 [TBL] [Abstract][Full Text] [Related]
19. Intravenous levetiracetam in children with seizures: a prospective safety study. Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804 [TBL] [Abstract][Full Text] [Related]
20. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study. Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]